References
- Adjei A, Rao S, Garren J, Menon G, Vadnere M. Effect of ion-pairing on 1-octanol-water partitioning of peptide drugs. I: The nonapeptide leuprolide acetate. Int J Pharm 1993; 90: 141–149
- Carino G, Mathiowitz E. Oral insulin delivery. Adv Drug Deliv Rev 1999; 35: 249–257
- Clement S, Still G, Kosutic G, McAllister RG. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: The glucose stabilization effects of HIM2. Diabetes Technol Ther 2002; 4: 449–466
- Cui F, Shi K, Zhang L, Tao A, Kawashima Y. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J Contr Rel 2006; 114: 242–250
- Cui F, Tao A, Cun D, Zhang L, Shi K. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. J Pharm Sci 2007; 96: 421–427
- Damgé C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Contr Rel 2007; 117: 163–170
- Damgé C, Michel C, Aprahamian M, Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 1988; 37: 246–251
- Damgé C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP. Nanocapsules as carriers for oral peptide delivery. J Contr Rel 1990; 13: 233–239
- Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm Res 1996; 13: 1838–1845
- Eaton RP, Allen RC, Schade DS, Standefer JC. ‘Normal’ insulin secretion: The goal of artificial insulin delivery systems?. Diabetes Care 1980; 3: 270–273
- Eneroth G, Ahlund K. Biological assay of insulin by blood sugar determination in mice. Acta Pharm Suec 1968; 5: 591–594
- Galindo-Rodriguez S, Allemann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion and nanoprecipitation methods. Pharm Res 2004; 21: 1428–1439
- Jintapattanakit A, Junyaprasert V, Mao S, Sitterberg J, Bakowsky U, Kissel T. Peroral delivery of insulin using chitosan derivatives: A comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharm 2007; 342: 240–249
- Kondoh M, Yagi K. Progress in absorption enhancers based on tight junction. Exp Opin Drug Deliv 2007; 4: 275–286
- Lewis G, Zinman B, Groenewound Y, Vranic M, Giacca A. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 1996; 45: 454–462
- Li Y, Ogris M, Pelisek J, Röedl W. Stability and release characteristics of poly (d,l-lactide-co-glycolide) encapsulated CaPi-DNA coprecipitation. Int J Pharm 2004; 269: 61–70
- Matsuura J, Powers ME, Manning MC, Shefter E. Structure and stability of insulin dissolved in 1-octanol. J Am Chem Soc 1993; 115: 1261–1264
- Meyer JD, Manning MC. Hydrophobic ion pairing: Altering the solubility properties of biomolecules. Pharm Res 1998; 15: 188–193
- Nandi A, Khakhar DV, Mehra A. Coalescence in surfactant-stabilized emulsions subjected to shear flow. Langmuir 2001; 17: 2647–2655
- Owens DR, Zinman B, Bolli G. Alternative routes of insulin delivery. Diab Med 2003; 20: 886–898
- Polaschegg E. Effect of physicochemical variables of regular insulin formulations on their absorption from the subcutaneous tissue. Diabetes Res Clin Pract 1998; 40: 39–44
- Ritschel WA, Ritschel GB, Ritschel BEC, Lucker PW. Rectal delivery system for insulin. Methods Find Exp Clin Pharmacol 1988; 10: 645–656
- Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q, Li Y, Hou S. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug. Int J Pharm 2008; 350: 320–329
- Sun S, Cui F, Kawashima Y, Liang N, Zhang L, Shi K, Yu Y. A novel insulin-sodium oleate complex for oral administration: Preparation, characterization and in vivo evaluation. J Drug Deliv Sci Tec 2008; 18: 239–243